Cargando…
The AvecNet Trial to assess whether addition of pyriproxyfen, an insect juvenile hormone mimic, to long-lasting insecticidal mosquito nets provides additional protection against clinical malaria over current best practice in an area with pyrethroid-resistant vectors in rural Burkina Faso: study protocol for a randomised controlled trial
BACKGROUND: Recent reductions in malaria in sub-Saharan Africa have been associated with increased coverage with long-lasting insecticidal nets (LLINs). Pyrethroids are currently the only insecticide class used for treating nets, and the rapid increase in resistance to pyrethroids in vector mosquito...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377002/ https://www.ncbi.nlm.nih.gov/pubmed/25873089 http://dx.doi.org/10.1186/s13063-015-0606-4 |
_version_ | 1782363830879256576 |
---|---|
author | Tiono, Alfred B Pinder, Margaret N’Fale, Sagnon Faragher, Brian Smith, Tom Silkey, Mariabeth Ranson, Hilary Lindsay, Steve W |
author_facet | Tiono, Alfred B Pinder, Margaret N’Fale, Sagnon Faragher, Brian Smith, Tom Silkey, Mariabeth Ranson, Hilary Lindsay, Steve W |
author_sort | Tiono, Alfred B |
collection | PubMed |
description | BACKGROUND: Recent reductions in malaria in sub-Saharan Africa have been associated with increased coverage with long-lasting insecticidal nets (LLINs). Pyrethroids are currently the only insecticide class used for treating nets, and the rapid increase in resistance to pyrethroids in vector mosquitoes may jeopardise future vector control. Nets containing a novel combination of permethrin, a pyrethroid, and pyriproxyfen, an insect juvenile hormone mimic, (PPF-LLIN) may enhance malaria control, as well as reducing the spread of pyrethroid-resistant mosquitoes. This trial will determine whether PPF-LLINs provide incremental protection against malaria over current best practice of LLINs and prompt treatment in an area with pyrethroid-resistant vectors. METHODS: A 2 armed cluster-randomised controlled trial will be conducted in Burkina Faso to assess whether PPF-LLIN (containing 2% permethrin and 1% pyriproxyfen w/w) provide better protection against clinical malaria in children than 2% permethrin-treated LLINs. Study subjects will be recruited and provided with LLINs at the start of the study. The LLINs will be exchanged for PPF-LLIN by cluster in a step-wedge fashion so 3 months before the end of the 2 year trial all participants will have a PPF-LLIN. The primary endpoint will be clinical malaria incidence measured by passive case detection in a cohort of children, aged 6 months to 5 years. Anaemia and parasite prevalence will also be measured in children during cross-sectional surveys. Exposure to malaria parasites will be assessed using light traps followed by identification of common vector species and their sporozoite infection rates. Safety evaluation will include recording of adverse events and pregnancy outcomes. The main endpoint analysis will include adjusting for distance between village clusters with different types of nets, as the impact of PPF-LLIN is likely to increase as larger areas are dominated by PPF-LLIN, reducing the spill over of mosquitoes from villages with LLINs. DISCUSSION: The step-wedge design is to measure the impact of an incrementally delivered environmental intervention where we expect the degree of control to be improved as more people use PPF-LLIN over a larger area. Trial findings will help inform policy makers on the effectiveness of PPF-LLIN nets for malaria control in areas of pyrethroid resistance. TRIAL REGISTRATION: ISRCTN21853394 – AvecNet, registered on 3 April 2013. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-015-0606-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4377002 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43770022015-03-29 The AvecNet Trial to assess whether addition of pyriproxyfen, an insect juvenile hormone mimic, to long-lasting insecticidal mosquito nets provides additional protection against clinical malaria over current best practice in an area with pyrethroid-resistant vectors in rural Burkina Faso: study protocol for a randomised controlled trial Tiono, Alfred B Pinder, Margaret N’Fale, Sagnon Faragher, Brian Smith, Tom Silkey, Mariabeth Ranson, Hilary Lindsay, Steve W Trials Study Protocol BACKGROUND: Recent reductions in malaria in sub-Saharan Africa have been associated with increased coverage with long-lasting insecticidal nets (LLINs). Pyrethroids are currently the only insecticide class used for treating nets, and the rapid increase in resistance to pyrethroids in vector mosquitoes may jeopardise future vector control. Nets containing a novel combination of permethrin, a pyrethroid, and pyriproxyfen, an insect juvenile hormone mimic, (PPF-LLIN) may enhance malaria control, as well as reducing the spread of pyrethroid-resistant mosquitoes. This trial will determine whether PPF-LLINs provide incremental protection against malaria over current best practice of LLINs and prompt treatment in an area with pyrethroid-resistant vectors. METHODS: A 2 armed cluster-randomised controlled trial will be conducted in Burkina Faso to assess whether PPF-LLIN (containing 2% permethrin and 1% pyriproxyfen w/w) provide better protection against clinical malaria in children than 2% permethrin-treated LLINs. Study subjects will be recruited and provided with LLINs at the start of the study. The LLINs will be exchanged for PPF-LLIN by cluster in a step-wedge fashion so 3 months before the end of the 2 year trial all participants will have a PPF-LLIN. The primary endpoint will be clinical malaria incidence measured by passive case detection in a cohort of children, aged 6 months to 5 years. Anaemia and parasite prevalence will also be measured in children during cross-sectional surveys. Exposure to malaria parasites will be assessed using light traps followed by identification of common vector species and their sporozoite infection rates. Safety evaluation will include recording of adverse events and pregnancy outcomes. The main endpoint analysis will include adjusting for distance between village clusters with different types of nets, as the impact of PPF-LLIN is likely to increase as larger areas are dominated by PPF-LLIN, reducing the spill over of mosquitoes from villages with LLINs. DISCUSSION: The step-wedge design is to measure the impact of an incrementally delivered environmental intervention where we expect the degree of control to be improved as more people use PPF-LLIN over a larger area. Trial findings will help inform policy makers on the effectiveness of PPF-LLIN nets for malaria control in areas of pyrethroid resistance. TRIAL REGISTRATION: ISRCTN21853394 – AvecNet, registered on 3 April 2013. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-015-0606-4) contains supplementary material, which is available to authorized users. BioMed Central 2015-03-25 /pmc/articles/PMC4377002/ /pubmed/25873089 http://dx.doi.org/10.1186/s13063-015-0606-4 Text en © Tiono et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol Tiono, Alfred B Pinder, Margaret N’Fale, Sagnon Faragher, Brian Smith, Tom Silkey, Mariabeth Ranson, Hilary Lindsay, Steve W The AvecNet Trial to assess whether addition of pyriproxyfen, an insect juvenile hormone mimic, to long-lasting insecticidal mosquito nets provides additional protection against clinical malaria over current best practice in an area with pyrethroid-resistant vectors in rural Burkina Faso: study protocol for a randomised controlled trial |
title | The AvecNet Trial to assess whether addition of pyriproxyfen, an insect juvenile hormone mimic, to long-lasting insecticidal mosquito nets provides additional protection against clinical malaria over current best practice in an area with pyrethroid-resistant vectors in rural Burkina Faso: study protocol for a randomised controlled trial |
title_full | The AvecNet Trial to assess whether addition of pyriproxyfen, an insect juvenile hormone mimic, to long-lasting insecticidal mosquito nets provides additional protection against clinical malaria over current best practice in an area with pyrethroid-resistant vectors in rural Burkina Faso: study protocol for a randomised controlled trial |
title_fullStr | The AvecNet Trial to assess whether addition of pyriproxyfen, an insect juvenile hormone mimic, to long-lasting insecticidal mosquito nets provides additional protection against clinical malaria over current best practice in an area with pyrethroid-resistant vectors in rural Burkina Faso: study protocol for a randomised controlled trial |
title_full_unstemmed | The AvecNet Trial to assess whether addition of pyriproxyfen, an insect juvenile hormone mimic, to long-lasting insecticidal mosquito nets provides additional protection against clinical malaria over current best practice in an area with pyrethroid-resistant vectors in rural Burkina Faso: study protocol for a randomised controlled trial |
title_short | The AvecNet Trial to assess whether addition of pyriproxyfen, an insect juvenile hormone mimic, to long-lasting insecticidal mosquito nets provides additional protection against clinical malaria over current best practice in an area with pyrethroid-resistant vectors in rural Burkina Faso: study protocol for a randomised controlled trial |
title_sort | avecnet trial to assess whether addition of pyriproxyfen, an insect juvenile hormone mimic, to long-lasting insecticidal mosquito nets provides additional protection against clinical malaria over current best practice in an area with pyrethroid-resistant vectors in rural burkina faso: study protocol for a randomised controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377002/ https://www.ncbi.nlm.nih.gov/pubmed/25873089 http://dx.doi.org/10.1186/s13063-015-0606-4 |
work_keys_str_mv | AT tionoalfredb theavecnettrialtoassesswhetheradditionofpyriproxyfenaninsectjuvenilehormonemimictolonglastinginsecticidalmosquitonetsprovidesadditionalprotectionagainstclinicalmalariaovercurrentbestpracticeinanareawithpyrethroidresistantvectorsinruralburkinafasostudyprot AT pindermargaret theavecnettrialtoassesswhetheradditionofpyriproxyfenaninsectjuvenilehormonemimictolonglastinginsecticidalmosquitonetsprovidesadditionalprotectionagainstclinicalmalariaovercurrentbestpracticeinanareawithpyrethroidresistantvectorsinruralburkinafasostudyprot AT nfalesagnon theavecnettrialtoassesswhetheradditionofpyriproxyfenaninsectjuvenilehormonemimictolonglastinginsecticidalmosquitonetsprovidesadditionalprotectionagainstclinicalmalariaovercurrentbestpracticeinanareawithpyrethroidresistantvectorsinruralburkinafasostudyprot AT faragherbrian theavecnettrialtoassesswhetheradditionofpyriproxyfenaninsectjuvenilehormonemimictolonglastinginsecticidalmosquitonetsprovidesadditionalprotectionagainstclinicalmalariaovercurrentbestpracticeinanareawithpyrethroidresistantvectorsinruralburkinafasostudyprot AT smithtom theavecnettrialtoassesswhetheradditionofpyriproxyfenaninsectjuvenilehormonemimictolonglastinginsecticidalmosquitonetsprovidesadditionalprotectionagainstclinicalmalariaovercurrentbestpracticeinanareawithpyrethroidresistantvectorsinruralburkinafasostudyprot AT silkeymariabeth theavecnettrialtoassesswhetheradditionofpyriproxyfenaninsectjuvenilehormonemimictolonglastinginsecticidalmosquitonetsprovidesadditionalprotectionagainstclinicalmalariaovercurrentbestpracticeinanareawithpyrethroidresistantvectorsinruralburkinafasostudyprot AT ransonhilary theavecnettrialtoassesswhetheradditionofpyriproxyfenaninsectjuvenilehormonemimictolonglastinginsecticidalmosquitonetsprovidesadditionalprotectionagainstclinicalmalariaovercurrentbestpracticeinanareawithpyrethroidresistantvectorsinruralburkinafasostudyprot AT lindsaystevew theavecnettrialtoassesswhetheradditionofpyriproxyfenaninsectjuvenilehormonemimictolonglastinginsecticidalmosquitonetsprovidesadditionalprotectionagainstclinicalmalariaovercurrentbestpracticeinanareawithpyrethroidresistantvectorsinruralburkinafasostudyprot AT tionoalfredb avecnettrialtoassesswhetheradditionofpyriproxyfenaninsectjuvenilehormonemimictolonglastinginsecticidalmosquitonetsprovidesadditionalprotectionagainstclinicalmalariaovercurrentbestpracticeinanareawithpyrethroidresistantvectorsinruralburkinafasostudyprotoco AT pindermargaret avecnettrialtoassesswhetheradditionofpyriproxyfenaninsectjuvenilehormonemimictolonglastinginsecticidalmosquitonetsprovidesadditionalprotectionagainstclinicalmalariaovercurrentbestpracticeinanareawithpyrethroidresistantvectorsinruralburkinafasostudyprotoco AT nfalesagnon avecnettrialtoassesswhetheradditionofpyriproxyfenaninsectjuvenilehormonemimictolonglastinginsecticidalmosquitonetsprovidesadditionalprotectionagainstclinicalmalariaovercurrentbestpracticeinanareawithpyrethroidresistantvectorsinruralburkinafasostudyprotoco AT faragherbrian avecnettrialtoassesswhetheradditionofpyriproxyfenaninsectjuvenilehormonemimictolonglastinginsecticidalmosquitonetsprovidesadditionalprotectionagainstclinicalmalariaovercurrentbestpracticeinanareawithpyrethroidresistantvectorsinruralburkinafasostudyprotoco AT smithtom avecnettrialtoassesswhetheradditionofpyriproxyfenaninsectjuvenilehormonemimictolonglastinginsecticidalmosquitonetsprovidesadditionalprotectionagainstclinicalmalariaovercurrentbestpracticeinanareawithpyrethroidresistantvectorsinruralburkinafasostudyprotoco AT silkeymariabeth avecnettrialtoassesswhetheradditionofpyriproxyfenaninsectjuvenilehormonemimictolonglastinginsecticidalmosquitonetsprovidesadditionalprotectionagainstclinicalmalariaovercurrentbestpracticeinanareawithpyrethroidresistantvectorsinruralburkinafasostudyprotoco AT ransonhilary avecnettrialtoassesswhetheradditionofpyriproxyfenaninsectjuvenilehormonemimictolonglastinginsecticidalmosquitonetsprovidesadditionalprotectionagainstclinicalmalariaovercurrentbestpracticeinanareawithpyrethroidresistantvectorsinruralburkinafasostudyprotoco AT lindsaystevew avecnettrialtoassesswhetheradditionofpyriproxyfenaninsectjuvenilehormonemimictolonglastinginsecticidalmosquitonetsprovidesadditionalprotectionagainstclinicalmalariaovercurrentbestpracticeinanareawithpyrethroidresistantvectorsinruralburkinafasostudyprotoco |